APO RESEARCH · REPORT
Octreotide
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Product & engineering
Understand the product.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Selected research
Market Structure
Global Octreotide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Read the full market overview
This report provides an overview of the global Octreotide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Octreotide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Octreotide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Octreotide market size, projected growth trends, production technologies, key applications, and end-use industries.
Octreotide Segment by Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Octreotide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Applications
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
Companies covered
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Octreotide Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Octreotide Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Octreotide Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Octreotide Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Octreotide Market Dynamics
- 2.1 Octreotide Industry Trends
- 2.2 Octreotide Industry Drivers
- 2.3 Octreotide Industry Opportunities and Challenges
- 2.4 Octreotide Industry Restraints
3 Octreotide Market by Manufacturers
- 3.1 Global Octreotide Revenue by Manufacturers (2021-2026)
- 3.2 Global Octreotide Sales by Manufacturers (2021-2026)
- 3.3 Global Octreotide Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Octreotide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Octreotide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Octreotide Manufacturers, Product Type & Application
- 3.7 Global Octreotide Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Octreotide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Octreotide Players Market Share by Revenue in 2025
- 3.8.3 2025 Octreotide Tier 1, Tier 2, and Tier 3
4 Octreotide Market by Type
- 4.1 Octreotide Type Introduction
- 4.1.1 Octreotide Injection
- 4.1.2 Octreotide Powder
- 4.1.3 Octreotide Microspheres
- 4.2 Global Octreotide Sales by Type
- 4.2.1 Global Octreotide Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Octreotide Sales by Type (2021-2032)
- 4.2.3 Global Octreotide Sales Market Share by Type (2021-2032)
- 4.3 Global Octreotide Revenue by Type
- 4.3.1 Global Octreotide Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Octreotide Revenue by Type (2021-2032)
- 4.3.3 Global Octreotide Revenue Market Share by Type (2021-2032)
5 Octreotide Market by Application
- 5.1 Octreotide Application Introduction
- 5.1.1 Treating Severe Diarrhea
- 5.1.2 Treating Acromegaly
- 5.1.3 Others
- 5.2 Global Octreotide Sales by Application
- 5.2.1 Global Octreotide Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Octreotide Sales by Application (2021-2032)
- 5.2.3 Global Octreotide Sales Market Share by Application (2021-2032)
- 5.3 Global Octreotide Revenue by Application
- 5.3.1 Global Octreotide Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Octreotide Revenue by Application (2021-2032)
- 5.3.3 Global Octreotide Revenue Market Share by Application (2021-2032)
6 Global Octreotide Sales by Region
- 6.1 Global Octreotide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Octreotide Sales by Region (2021-2032)
- 6.2.1 Global Octreotide Sales by Region (2021-2026)
- 6.2.2 Global Octreotide Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Octreotide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Octreotide Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Octreotide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Octreotide Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Octreotide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Octreotide Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Octreotide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Octreotide Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Octreotide Revenue by Region
- 7.1 Global Octreotide Revenue by Region
- 7.1.1 Global Octreotide Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Octreotide Revenue by Region (2021-2026)
- 7.1.3 Global Octreotide Revenue by Region (2027-2032)
- 7.1.4 Global Octreotide Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Octreotide Revenue (2021-2032)
- 7.2.2 North America Octreotide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Octreotide Revenue (2021-2032)
- 7.3.2 Europe Octreotide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Octreotide Revenue (2021-2032)
- 7.4.2 Asia-Pacific Octreotide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Octreotide Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Octreotide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Octreotide Product Portfolio
- 8.1.5 Novartis Recent Developments
- 8.2 Sun Pharmaceutical
- 8.2.1 Sun Pharmaceutical Company Information
- 8.2.2 Sun Pharmaceutical Business Overview
- 8.2.3 Sun Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharmaceutical Octreotide Product Portfolio
- 8.2.5 Sun Pharmaceutical Recent Developments
- 8.3 Chengdu Tiantaishan pharmaceutical
- 8.3.1 Chengdu Tiantaishan pharmaceutical Company Information
- 8.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
- 8.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
- 8.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
- 8.4 Sinopharm A-Think Pharmaceuticals
- 8.4.1 Sinopharm A-Think Pharmaceuticals Company Information
- 8.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
- 8.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
- 8.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
- 8.5 Sihuan Pharmaceutical Holdings Group
- 8.5.1 Sihuan Pharmaceutical Holdings Group Company Information
- 8.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
- 8.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
- 8.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
- 8.6 Shanghai Soho-Yiming Pharmaceuticals
- 8.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 8.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 8.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
- 8.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 8.7 Yibin Pharmaceutical
- 8.7.1 Yibin Pharmaceutical Company Information
- 8.7.2 Yibin Pharmaceutical Business Overview
- 8.7.3 Yibin Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
- 8.7.5 Yibin Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Octreotide Value Chain Analysis
- 9.1.1 Octreotide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Octreotide Production Mode & Process
- 9.2 Octreotide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Octreotide Distributors
- 9.2.3 Octreotide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst